Key result
Diabetes induces cardiac electrical remodeling and QT prolongation, increasing life-threatening ventricular arrhythmia risk.
Why the study?
What are the electrical features of the diabetic myocardium and the cardiovascular safety considerations for antidiabetic drugs?
Design
Review
Authors
Loading...
May increase arrhythmia risk in diabetes; leaves open prospective trials on antidiabetic drug effects on QT and electrophysiology.
What are the electrical features of the diabetic myocardium and the cardiovascular safety considerations for antidiabetic drugs?
This review highlights the importance of evaluating QT prolongation and arrhythmic risk in diabetic patients and assessing the cardiovascular safety of new antidiabetic drugs.
Gallego et al. (2021) conducted a review in Diabetes and Diabetic Cardiomyopathy. Diabetes induces cardiac electrical remodeling and QT prolongation, increasing the risk of life-threatening ventricular arrhythmias and necessitating careful cardiovascular safety evaluation of new drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: